The United States Patent and Trademark Office (USPTO) has published a new patent application, US20260083665A1, detailing "Implantable and Biodegradable Drug Delivery Devices and Methods of Use Thereof." The application describes a device designed to deliver active pharmaceutical ingredients (API) directly to a target tissue site. It features at least two layers, with one layer containing the API and a biodegradable polymer that degrades faster than a second, non-API layer, thereby controlling the release of the API to prevent off-target diffusion.

This patent publication is primarily an intellectual property filing and does not impose direct regulatory obligations or compliance deadlines on pharmaceutical or medical device companies. However, it signifies potential innovation in drug delivery systems. Companies operating in this space, particularly those developing implantable devices or novel drug formulations, should be aware of this filing as it may impact their own research and development strategies or patent landscape. The filing date was November 25, 2025, and the publication date is March 26, 2026.